ProCE Banner Activity

My Approach to ALL Diagnosis and Initial Workup

Clinical Thought
Here’s my take on important considerations for ALL diagnosis and initial workup that inform treatment decisions.

Released: October 16, 2019

Expiration: October 14, 2020

No longer available for credit.

Share

Faculty

Daniel J. DeAngelo

Daniel J. DeAngelo, MD, PhD

Chief, Division of Leukemia
Dana-Farber Cancer Institute
Professor of Medicine
Harvard Medical School
Boston, Massachusetts

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by educational grants from

Amgen, Inc.

Jazz Pharmaceuticals Inc

Pfizer, Inc.

Faculty Disclosure

Primary Author

Daniel J. DeAngelo, MD, PhD

Chief, Division of Leukemia
Dana-Farber Cancer Institute
Professor of Medicine
Harvard Medical School
Boston, Massachusetts

Daniel J. DeAngelo, MD, PhD, has disclosed that he has received consulting fees from Amgen, Autolus Therapeutics, Celgene, Forty Seven, Incyte, Jazz, Novartis, Pfizer, Shire, and Takeda and funds for research support from AbbVie, GlycoMimetics, and Novartis.